Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020


Phacilitate Leaders Europe Agenda


Closing Roundtable Discussions

18 Sep 2019
Patient Access & Healthcare

Table 1: Topic TBC

Table 2: Topic TBC

Table 3: Topic TBC

Table 4: Topic TBC

Peter Olagunju, Vice President Patient Operations - bluebird bio
Mark Flower, Vice President, Business Development and Strategic Partnerships - Be The Match BioTherapies
Sven Kili, Founder - Sven Kili Consulting
Marc Turner, Medical Director - Scottish National Blood Transfusion Service
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd